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Abstract
Significance: Since the discovery and structural characterization of bacillithiol (BSH), the biochemical func-
tions of BSH-biosynthesis enzymes (BshA/B/C) and BSH-dependent detoxification enzymes (FosB, Bst, GlxA/
B) have been explored in Bacillus and Staphylococcus species. It was shown that BSH plays an important role
in detoxification of reactive oxygen and electrophilic species, alkylating agents, toxins, and antibiotics.
Recent Advances: More recently, new functions of BSH were discovered in metal homeostasis (Zn buffering,
Fe-sulfur cluster, and copper homeostasis) and virulence control in Staphylococcus aureus. Unexpectedly,
strains of the S. aureus NCTC8325 lineage were identified as natural BSH-deficient mutants. Modern mass
spectrometry-based approaches have revealed the global reach of protein S-bacillithiolation in Firmicutes as an
important regulatory redox modification under hypochlorite stress. S-bacillithiolation of OhrR, MetE, and
glyceraldehyde-3-phosphate dehydrogenase (Gap) functions, analogous to S-glutathionylation, as both a redox-
regulatory device and in thiol protection under oxidative stress.
Critical Issues: Although the functions of the bacilliredoxin (Brx) pathways in the reversal of S-bacillithiolations
have been recently addressed, significantly more work is needed to establish the complete Brx reduction pathway,
including the major enzyme(s), for reduction of oxidized BSH (BSSB) and the targets of Brx action in vivo.
Future Directions: Despite the large number of identified S-bacillithiolated proteins, the physiological rele-
vance of this redox modification was shown for only selected targets and should be a subject of future studies. In
addition, many more BSH-dependent detoxification enzymes are evident from previous studies, although their
roles and biochemical mechanisms require further study. This review of BSH research also pin-points these
missing gaps for future research. Antioxid. Redox Signal. 28, 445–462.
Keywords: Bacillus subtilis, Staphylococcus aureus, bacillithiol, BSH biosynthesis, metal homeostasis,
methylglyoxal, S-bacillithiolation, bacilliredoxin
Historical Context: Glutathione and the Discovery
of Alternative Low-Molecular-Weight Thiols
Low-molecular-weight (LMW) thiols serve a criticalprotective role in cells by helping maintain cytosolic pro-
teins in their reduced state and as protection against reactive
oxygen species (ROS) and reactive electrophilic species, anti-
biotics, as well as heavymetals. Glutathione (GSH), a tripeptide
with composition c-L-glutamyl-L-cysteinylglycine (Fig. 1), is,
by far, the best studied member from this class of compounds.
Although thiols were detected in tissues in the late 19th
century, the discovery of GSH is appropriately attributed to the
celebrated biochemist Sir FredrickHopkins in 1921, co-winner
(with Christiaan Eijkman) of the 1929 Nobel Prize in Phy-
siology or Medicine for his discovery of vitamins. In his
seminal paper on GSH (53), Hopkins begins by giving credit to
the studies of Joseph de Rey-Pailhade (20), several decades
prior (1888), that led to the description of ‘‘philothion’’ as a
cellular reductant. Despite uncertainty regarding the precise
chemical composition, Hopkins proposed the name glutathione
for what he surmised was a dipeptide containing Glu and Cys:
Provisionally, for easy reference, the name Glutathione will
perhaps be admissible. It leaves a link with the historic Phi-
1Department of Microbiology, Cornell University, Ithaca, New York.
2Institute for Biology-Microbiology, Freie Universita¨t Berlin, Berlin, Germany.
ª Pete Chandrangsu, et al., 2018; Published by Mary Ann Liebert, Inc. This article is available under the Creative Commons License CC-
BY-NC (http://creativecommons.org/licenses/by-nc/4.0). This license permits non-commercial use, distribution and reproduction in any med-
ium, provided the original work is properly cited. Permission only needs to be obtained for commercial use and can be done via RightsLink.
ANTIOXIDANTS & REDOX SIGNALING
Volume 28, Number 6, 2018
Mary Ann Liebert, Inc.
DOI: 10.1089/ars.2017.7057
445
lothion, has the same termination as Peptone, which has long
served as a name for the simpler peptides, and is a sufficient
reminder that the dipeptide contains glutamic acid linked to a
sulphur compound (53).
Doubts about the proposed chemical composition soon
emerged. Hopkins acknowledged this, and in 1929 published
evidence of the general tripeptide composition of GSH as
well as methods for its large-scale purification (54). These
studies revealed that GSH does not contain a thione (C = S)
moiety, but instead has a thiol (C-SH) (Fig. 1), but the name
glutathione has since been retained.
By the 1950s, the chemistry of thiols had been thoroughly
investigated, and Barron (6) could conclude that GSH, as the
major LMW thiol in cells, ‘‘...protects essential -SH groups
from oxidation, and it protects the tissues from the toxic effects
of heavy metals.’’ By this time, the impression had emerged
that GSH was a universal constituent of cells (6). Despite the
proclaimed ubiquity of GSH, by the mid-1970s, Robert Fa-
hey’s group had developed evidence pointing to the absence of
GSH in several species of bacteria (28).
Following up on this insight, the alternative thiol desig-
nated mycothiol (MSH) was purified and structurally char-
acterized from Streptomyces sp. AJ 9463 in the disulfide form
(119), from Mycobacterium bovis (125) and from Strepto-
myces clavuligerus (94), and shown to be the major LMW
thiol in most actinomycetes (Fig. 1) (92). As discussed later,
the biosynthetic pathways leading to MSH and to bacillithiol
(BSH) are closely related. The discovery and properties of
MSH have been recently reviewed (27, 59).
In addition to MSH, some mycobacteria also produce an-
other LMW thiol, ergothioneine (EGT; 2-mercaptohistidine
trimethylbetaine), originally discovered in the ergot fungus
as reviewed in (26). Chemically, EGT is distinct from other
LMW thiols in that a major fraction exists as the thione tau-
tomer. In addition to MSH, other alternative thiols have also
become appreciated for their roles as alternative LMW thiols.
One of the first to be described, trypanothione [T(SH)2; Bis-
glutathionylspermidine], is found in trypanosomatid para-
sites and consists of two GSH molecules linked by spermidine
(29). Trypanosomes also contain ovothiol A (N1-methyl-4-
mercaptohistidine).
Bacillithiol: Discovery, Structure Determination,
and Biosynthetic Pathway
Although the absence of GSH in many bacteria was ap-
preciated by 1978 (28), nearly 20 years would elapse before
bacillithiol (BSH)would be identified as themajor LMW thiol
in many Firmicutes (low GC, Gram-positive bacteria). This
phylum is represented by themodel organismBacillus subtilis
and includes several important human pathogens. BSH has, to
date, been documented in Bacillus and Staphylococcus spp.,
Streptococcus agalactiae, andDeinococcus radiodurans (97).
In the interim, it was speculated that the function of GSH in
these organisms might have been subsumed by Cys (10) or
coenzyme A (CoASH) (21). The presence of a specific CoA-
disulfide reductase in Staphylococcus aureus and Bacillus
anthracis supports the notion that CoASH is reversibly oxi-
dized in vivo and may serve as an LMW thiol (21).
BSH was initially detected by HPLC analysis, together with
CoASH, as an abundant 398 Da LMW thiol during studies of
thiol-dependent enzymes in B. anthracis (99). Independently,
a thiol of this samemass was detected bymass spectrometry as
the major adduct for in vivo oxidized OhrR protein in B.
subtilis (64). OhrR is a DNA-binding protein with a single
redox-active Cys residue in each monomer and responds to
thiol oxidants by formation of mixed disulfides, including, as a
dominant product, the S-bacillithiolated protein.
Following up on this initial discovery, rapid progress was
made in a coordinated multi-laboratory effort that led to the
determination of the chemical structure for BSH, and insights
into its distribution (97) and biosynthetic pathway (40). The
identification of the biosynthetic pathway enabled the gen-
eration of mutant strains lacking BSH, and initial insights into
FIG. 1. Structures of major LMW thiols in bacteria. Glutathione is utilized as the major LMW thiol in eukaryotes and
Gram-negative bacteria, mycothiol in Actinomycetes, and BSH in Firmicutes. Coenzyme A (CoASH) also serves as an
LMW thiol in Staphylococcus aureus and Bacillus anthracis. BSH, bacillithiol; LMW, low molecular weight.
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its physiological role. Working on the general assumption
that BSH has likely supplanted GSH as an enzyme cofactor in
these organisms, it was also possible to predict the presence
of various different types of BSH-dependent enzymes (e.g.,
bacillithiol-S-transferases [BST], analogous to glutathionyl-
S-transferases) and redox partners (e.g., bacilliredoxins
[Brx], analogous to glutaredoxins). Even at this early stage
(only two prior research papers on BSH had appeared), this
enabled the presentation of an early preview of how the BSH
field might evolve, and readers are referred to this prior re-
view for a more detailed discussion of these early steps,
which provides a context for the present review (50).
The structure of BSH was determined, after purification
of the S-bimane derivative from D. radiodurans, to be the
a-anomeric glycoside of L-cysteinyl-D-glucosamine with L-
malic acid (97). Based on the chemical similarities between
MSH and BSH, it was possible to identify candidate genes for
the first two steps in BSH biosynthesis by homology (40).
This led to the identification of a cluster of co-transcribed
genes in B. subtilis that includes bshA (encoding a L-malic
acid glycosyltransferase) and bshB1 (one of two partially
redundant deacetylases for conversion of GlcNAc-Mal to
GlcN-Mal). This same operon also includes mgsA (a me-
thylglyoxal synthase), which is of interest since (as discussed
below) BSH plays a major role in methylglyoxal (MG) de-
toxification (11). This gene cluster is immediately upstream
of and co-directional with the panBCD operon encoding
enzymes in the CoASH biosynthetic pathway.
The bshC gene could not be identified by homology-based
searches, but was revealed by phylogenomic comparisons
(using the EMBL STRINGS web-based tool) as a gene with
a high co-occurrence (and occasional co-localization) with
bshA in bacterial genomes (40). The bshC gene is transcribed
both from its own promoter and also as part of a two-gene
operon with another predicted pantothenate biosynthesis
gene, panE (ylbQ) (37).
The significance of this gene clustering and possible co-
ordinate regulation is not yet understood, but an obvious
suggestion is that the synthesis of CoASH and BSH may be
positively correlated (50). Indeed, in B. subtilis, all of the
genes required for BSH synthesis are upregulated in response
to disulfide stress (e.g., diamide) through the action of the Spx
transcription factor (37). A similar induction has also been
documented in S. aureus (111). More broadly, genes for both
BSH synthesis and BSH-dependent detoxification reactions
are upregulated by several reactive oxidants and reactive
electrophiles, as noted in several studies in B. subtilis, B.
anthracis, and S. aureus [reviewed in Perera et al. (107)].
In addition to providing a candidate gene for the last and
missing step in BSH biosynthesis (bshC), phylogenomic
profiling also provided an intriguing list of genes encoding
proteins that are likely to function in core BSH metabolism.
These included several genes of previously unassigned
function (so-called y-genes). The ypdA gene encodes a pu-
tative thioredoxin reductase (TrxR) homolog and is postu-
lated to function as a bacillithiol disulfide (BSSB) reductase,
although experimental evidence is still lacking. Two others
(yqiW and yphP) encode proteins with DUF1094 domains
(domain of unknown function containing a conserved Cys-x-
Cys motif), and YphP was shown to be active as a disulfide
isomerase (22). This led to the prediction that these proteins
might function as Brx for the reduction of S-bacillithiolated
proteins, as described later. Finally, ytxJwas found to encode
another putative redox-active protein related to Trx that also
presumably functions in BSH metabolism.
Identification of the biosynthetic genes for BSH enabled the
generation of mutants lacking this thiol, confirming that BSH
is non-essential. Mutants lacking the ability to synthesize
BSH are sensitive to a variety of oxidative and electrophilic
stress conditions in B. subtilis and S. aureus (14, 15, 40, 111,
114). Moreover, it quickly became apparent that a previous
suggestion that the B. subtilis FosB fosfomycin resistance
protein might utilize Cys as a cofactor (10) was incorrect.
FosB (as described in more detail later) is a BSH-dependent
enzyme, and cells lacking either fosB or BSH biosynthesis are
equally sensitive to fosfomycin in B. subtilis and S. aureus
(40, 111). In practice, this provides a very convenient (al-
though indirect) assay for BSH levels in B. subtilis (40).
Chemical Properties of BSH
A key challenge for the further investigation of BSH was
the need to obtain quantities that are sufficient for chemical
and biochemical characterization. The development of
methods for the chemical synthesis of BSH ultimately met
this need. Chris Hamilton reported both a complete chemical
synthesis and a hybrid chemoenzymatic route taking advan-
tage of the ability of purified BshA to provide the D-GlcNAc-
L-Mal precursor (121). These approaches provided access to
not only BSH but also BSSB and to the biosynthetic inter-
mediates GlcNAc-Mal and GlcN-Mal (Fig. 2). A complete
chemical synthesis was also reported by Richard Arm-
strong’s laboratory in which BSH could be obtained in 8–9%
yield after 11 chemical steps (62). Purified BSH has facili-
tated the development of a detailed understanding of the re-
dox chemistry and ionization behavior of BSH (120), the
generation of specific BSH antibodies (an important tool for
the study of S-bacillithiolation) (15), and provides a neces-
sary cofactor for the study of BSH-dependent enzymes.
A detailed chemical study of BSH redox and ionization
properties indicates that the BSH thiol is more acidic than
Cys or GSH, with a higher fraction in the reactive thiolate
state at physiological pH (120). For example, at pH 7.7, an
estimated 22% of BSH is in the bacillithiolate (BS-) form
compared with 14.5% for Cys. The standard thiol redox
potential for the BSH, BSSB couple (-221mV) is much
closer to that of free Cys (-223mV) compared with GSH
(-240mV). Considering the relative abundance of Cys,
CoASH, and BSH in the cell, it was concluded that BSH
(which is present at levels near 1mM during growth in B.
subtilis and S. aureus) is the dominant LMW thiol, with
levels of the BSH thiolate exceeding those of CoASH and
Cys thiolates by*10–100-fold (111, 120).
The chemistry of LMW thiol redox buffers is dominated
by the interconversion of the reduced (thiol) and oxi-
dized (disulfide) forms, and this chemistry accounts for their
role in maintaining proteins in their reduced states in the
cytosol. However, the thiolate anion can also serve as a nu-
cleophile in conjugate addition reactions as commonly em-
ployed in detoxification pathways. For BSH, these reactions
are mediated by BST enzymes, analogous to the well-
characterized GST enzymes (Fig. 3A, B). The best charac-
terized representative for this type of enzyme to date is FosB,
as noted earlier.
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Oxidized disulfides can also react with hydrogen sulfide
(H2S), a metabolite produced by sulfate-reducing bacteria
and also serving as a secondary messenger in mammalian
systems (7). H2S exists predominantly as the hydrosulfide
anion (HS-), which reacts with BSSB to generate BSH and
BSSH (bacillithiol persulfide). S. aureus was recently shown
to contain an inducible system that functions to detoxify re-
active persulfides. The CstB protein, a persulfide dioxygen-
ase sulfurtransferase, oxidizes BSSH (as well as other LMW
thiol persulfides) in the presence of sulfite to generate re-
duced thiols (BSH) and thiosulfate (122). These authors also
suggest that previously noted enzymes with a homology to
CoASH disulfide reductases (CoA disulfide reductase-
rhodanese homology domain protein; CoADR-RHD) may
actually function as reductases for the CoASSH persulfide.
The general prevalence of persulfides in bacterial physiology,
and the various means for their detoxification, is not yet fully
understood.
Biochemical Mechanism of BSH Biosynthesis
Since BSH plays a critical role in antibiotic detoxifica-
tion and oxidative stress responses, the enzymes involved in
BSH biosynthesis are attractive targets for novel antibiotic
development. In fact, S. aureus strains unable to produce
BSH are compromised for survival in the presence of mac-
rophages and neutrophils (111). BshA, BshB, and BshC
catalyze the enzymatic synthesis of BSH (Fig. 2). BshA is
homologous to Mycobacterium tuberculosis MshA and is a
GT-4 class glycosyltransferase that is required for the first
committed step in BSH biosynthesis. BshA catalyzes the
addition of UDP-N-acetylglucosamine (UDP-GlcNAc) to L-
malate through a metal-independent SN1-like mechanism,
forming N-acetylglucosaminyl-malate (GlcNAc-Mal) and
free UDP (130, 133). Structural and functional studies sug-
gest that the release of the UDP-leaving group and nucleo-
philic attack by L-malate occur on the same face of the
hexose sugar and are asynchronous, resulting in the forma-
tion of a short-lived oxocarbenium intermediate (133).
The second step of BSH biosynthesis is catalyzed by BshB,
an N-acetylhydrolase, that generates glucosamine malate
(GlcN-Mal) from GlcNAc-Mal. Genetic studies indicate the
presence of one or more functionally redundant proteins in B.
subtilis, B. anthracis, and B. cereus (31, 40). In B. subtilis,
strains lacking BshB1 still produced detectible levels of BSH
(40). However, BSH is completely absent on inactivation of
both BshB1 and a second deacetylase BshB2, encoded by
bshB2 (40). The same overlapping roles in BSH synthesis
were observed for the two BshB-paralogs BA1557 and
BA3888 in B. anthracis as well as for BC1534 and BC3461
in B. cereus (31). Biochemical evidence was provided that
both BshB-paralogs (BA1557 and BA3888) and the ortho-
logs in B. cereus have BshB activity and catalyze the N-
deacetylation of GlcNAc-Mal (31). In contrast, S. aureus
only encodes a single BshB-like protein that is essential for
BSH synthesis and has a dual function as BSH conjugate
amidase (Bca) (114).
Redundancy has been observed also forMSH biosynthesis,
where the deacetylation can be carried out by either the
BshB-like enzyme MshB or the ‘‘moonlighting’’ enzyme
Mca (mycothiol-S-conjugate amidase). The primary role of
Mca is in detoxification of xenobiotic compounds through the
cleavage of MSH conjugates, resulting in GlcN-myo-inositol
and the Cys-S-conjugate (mercapturic acid) that is exported
from the cell (93).
Biochemical studies of the BshB-paralogs of B. anthracis
and B. cereus identified only BA3888 as a bacillithiol-S-
conjugate amidase (Bca) able to hydrolyze the amide linkage
of bacillithiol-S-bimane (BSmB) to liberate GlcNAc-Mal
(31). The reaction proceeds via a Zn2+ dependent acid-base
catalysis. The active site is highly conserved, the Zn2+ is
coordinated by two histidine residues and one aspartate
(His12, His113, and Asp15), and the residues involved in
catalysis await identification. Bca activity is highly specific to
FIG. 2. Biosynthesis pathway of BSH and BSH-dependent detoxification. In the BSH synthesis pathway of Bacillus
subtilis, the glycosyltransferase BshA first adds GlcNAc to malate-producing GlcNAc-Mal. Then, the paralog N-
deacetylases BshB1 and BshB2 catalyze deacetylation of GlcNAc-Mal, and BshC adds cysteine (presumably in an un-
identified activated form) to GlcN-Mal, producing BSH. Detoxification of toxins, xenobiotics, or electrophiles involves their
conjugation with BSH by the BSH-S-transferase BstA, generating BS-conjugates that are cleaved by the deacetylase BshB2
(Bca) to CysS-conjugates and GlcN-Mal used for BSH recycling. The CysS-conjugates are exported from the cells as
mercapturic acid derivatives. In S. aureus, only one BshB-like enzyme is present that functions both as deacetylase and
amidase and is essential for BSH biosynthesis.
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the methyl aglycone, as suggested by its low enzymatic ac-
tivity when tested with BSH analogs where the methyl agly-
cone was replaced with an uncharged methyl or benzyl
group. The in vivo contribution of Bca to BSH biosynthesis
and the physiological substrates of Bca remain to be identified.
The addition of Cys to GlcN-Mal, the final step in BSH
biosynthesis, is catalyzed by the putative cysteine ligase,
BshC. BshC was identified by a phylogenomic analysis for
genes whose presence was correlated with the presence of
BshA and BshB utilizing the STRING protein interaction
network tool (40). Strains lacking BshC are unable to produce
BSH and accumulate elevated levels of the BSH precursor
GlcN-Mal (40). Interestingly, the reaction catalyzed by BshC
is unknown and has yet to be reconstituted in vitro, possibly
due to the absence of a required cofactor, substrate, or pro-
tein. Structural and functional studies suggest that BshC
forms a dimer in solution through interactions between an
extended coiled-coil domain from each subunit and that the
BshC active sites are solvent exposed, which may allow for
access by an additional protein involved in catalysis (132).
BSH and Detoxification
Fosfomycin and other antibiotics
LMW thiols play an important role in the detoxification
of xenobiotic compounds and antibiotics. The most well
understood LMW-based detoxification mechanism involves
thiol-S-transferases, which catalyse the reaction of LMW
thiols to a variety of substrates. The first characterized BST
was FosB, involved in the detoxification of fosfomycin
(Fig. 3A) (62, 115, 128). Fosfomycin is a broad-spectrum
antibiotic that is also used in clinical practice to treat
methicillin-resistant S. aureus (MRSA) infections (84, 127).
Fosfomycin inhibits the first step in cell wall synthesis
through covalent modification of the active site cysteine of
the MurA enzyme.
To counter the action of this antibiotic, bacteria have
evolved fosfomycin detoxification enzymes. B. subtilis and S.
aureus encode FosB, an Mn2+-dependent BST. FosB inacti-
vates fosfomycin by catalyzing the nucleophilic addition of
BSH to the C2 position of the fosfomycin epoxide ring,
FIG. 3. The functions of BSH-dependent detoxification enzymes in B. subtilis and S. aureus. BSH functions in
detoxification of reactive oxygen and electrophilic species, HOCl, and antibiotics, such as fosfomycin in B. subtilis and S. aureus.
(A) BSH is a cofactor for the thiol S-transferase FosB that adds BSH to fosfomycin for its detoxification. (B) Electrophiles,
xenobiotics, and toxins (RX) are conjugated to BSH by the BSH S-transferase BstA to form BS-conjugates (BSR), which are
cleaved by the BSH S-conjugate amidase BshB2 (Bca) to CysSR and a mercapturic acid (AcCySR) that is exported from the cell.
(C) BSH functions in methylglyoxal detoxification as a cofactor for the glyoxalases I/II (GlxA/B) in B. subtilis. GlxA converts
BS-hemithioacetal to S-lactoyl-BSH that is hydrolyzed by GlxB to D-lactate. (D) AdhA is a thiol-dependent formaldehyde
dehydrogenase that is induced under FA stress (98), likely converting S-hydroxymethyl-BSH to S-formyl-BSH. In the final step,
BSH and formate are released by an unidentified S-formyl-BSH hydrolase. (E) Unknown thiol-dependent peroxidases or
peroxiredoxins (Bpx) might function in peroxide detoxification. Question marks indicate uncharacterized reactions.
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resulting in an inactive BS-fosfomycin complex (115). Strains
lacking FosB or BSH are hypersensitive to fosfomycin and the
increase in sensitivity is comparable to strains lacking both
FosB and BSH, indicating that FosB utilizes BSH as a thiol
substrate (40). In support of this hypothesis, biochemical
studies demonstrated that S. aureus FosB is significantly more
active in the presence of BSH than other LMW thiols (115).
A second class of BSTs comprised members of the DinB/
YfiT superfamily of thiol transferases, which utilize a thiol
cofactor to detoxify reactive electrophiles and xenobiotics
(Fig. 3B). B. subtilis YfiT was identified as a putative BST by
structural homology to the mycothiol-S-transferase (RV0443)
found inM. tuberculosis (96). In vitro studies monitoring the
reaction of the electrophilic compound monochlorobimane
with BSH demonstrated that YfiT (96) and BstA (106), a
structural homolog found in S. aureus, indeed, function as
BSTs and are highly specific for BSH as a thiol substrate. The
relevant compounds detoxified by BSTs in vivo are currently
unknown. The only DinB/YfiT family protein with an iden-
tified function in vivo is the MSH-dependent maleylpyruvate
isomerase (ngcl2918) from Corynebacterium glutamicum,
which is essential for growth on aromatic compounds as a
carbon source (32).
BSTs may also be involved in the detoxification of en-
dogenously produced toxins that are byproducts or interme-
diates during secondary metabolite biosynthesis. In fact, toxic
metabolites that are produced during actinorhodin biosyn-
thesis by Streptomyces coelicolor appear to be detoxified by
formation of an MSH-S-conjugate (126). The formation of
this conjugate may be dependent on a DinB/YfiT-like protein.
Toxic electrophiles
The discovery of BSH as themajor LMW thiol inB. subtilis
led us to postulate that BSH may serve a protective function
against the toxic dicarbonyl compoundMG in amanner that is
functionally analogous to GSH (Fig. 3C). The first hint came
from the observation that the gene encoding MGS, mgsA, is
co-transcribed with the genes encoding the first two enzymes
in the BSH biosynthetic pathway, bshA and bshB1. In fact,
strains lacking BSH are more sensitive to added MG (40).
MG, an a,b unsaturated aldehyde, is a toxic, endogenous
byproduct of glycolysis, synthesized by MGS under condi-
tions of excess carbon or phosphate limitation due to an
imbalance between the rate of carbon acquisition and the
lower segment of glycolysis (129). The main role of MGS is
to restore inorganic phosphate levels. As an electrophile, MG
can modify guanine bases in DNA, leading to DNA damage
and an increased rate of mutation in surviving cells (33).
Furthermore, MG can react with arginine, lysine, and cyste-
ine residues in proteins, resulting in protein inactivation (72).
The major mechanism of protection from MG in Escher-
ichia coli is the GSH-dependent acidification of the cytoplasm
mediated by the KefGB and KefFC K+ efflux systems (34).
Exposure to MG leads to the spontaneous formation of the
GSH adduct hemithioacetal (HTA). Glyoxalase I (GlxI) cat-
alyzes the formation of S-lactoylglutathione (SLG) fromHTA
(77). Subsequently, glyoxalase II converts SLG to D-lactate
and regenerates GSH (102). KefGB and KefFC K+ efflux
systems are directly inhibited by GSH and activated by GSH
adducts. Thus, the SLG intermediate is critical for protection
from MG stress as it is required for the full activation of the
KefGB and KefFC K+ efflux pumps (77, 87). The H+ influx
that accompanies the KefGB and KefFC-mediated K+ efflux
leads to the cytoplasmic acidification that is sufficient to
confer resistance to MG (34). Interestingly, protection from
MG by cytoplasmic acidification does not increase the rate of
MG detoxification (33, 34). Rather, cytoplasmic acidification
likely protects cells from MG and other electrophiles by
protonating nucleophilic residues on DNA, thereby prevent-
ing alkylation of DNA by electrophiles (33).
B. subtilis encodes a BSH-dependent MG-detoxification
pathway (Figs. 3C and 4) (11). Null mutants of the glyoxalase
I and II homologs, GlxA (formerly YwbC) and GlxB (for-
merly YurT), respectively, are more sensitive to MG and
function in the same genetic pathway as BSH and a putative
BSH-gated K+/H+ antiporter, KhtSTU (formerly YhaSTU).
Upon MG stress, intracellular pH decreases *0.4U, as
FIG. 4. BSH-dependent detoxification of methylglyoxal, leading to cytoplasmic acidification. Methylglyoxal can be
produced as a byproduct of the glycolysis from DHAP. Methylglyoxal reacts spontaneously with BSH, forming BS-
hemithioacetal, which is converted to S-lactoyl-BSH by the glyoxalase-I (GlxA) and to lacatate by the glyoxalase-II (GlxB).
S-lactoyl-BSH activates the potassium proton antiporter KhtSTU for K-efflux and proton import, leading to cytoplasmic
acidification that likely inhibits interaction of methylglyoxal with the DNA to prevent DNA damage. BSH inhibits the
antiporter KhtSTU. DHAP, dihydroxyacetone phosphate.
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measured by an intracellular GFP-based pH reporter (Fig. 4).
This cytoplasmic acidification is sufficient for protection
against MG, since cells treated with the weak membrane-
permeant acid sodium acetate before MG exposure are less
sensitive to MG.
A GSH-independent MG detoxification pathway is also
present in E. coli, in which MG is converted directly to D-
lactate by the glyoxalase III enzyme, HchA. Using the Phyre2
structural homology search tool, a glyoxalase III homolog,
GlxC (formerly YdeA) in B. subtilis was identified (11).
GlxC null mutants are more sensitive to MG than wild-type
cells, although to a lesser extent than a BSH null mutant. The
MG sensitivity of the glcX bshC double mutant was additive
when compared with the glxC and bshC single mutants,
which suggests that GlxC is a BSH-independent glyoxalase
III enzyme and that the major detoxification pathway is BSH
dependent (11).
Methanotrophic and methylotrophic bacteria generate for-
maldehyde (FA) as an intermediate during the oxidation of
methane to carbon dioxide. FA is a toxic carbonyl compound
that, similar to MG, is a reactive electrophile and can react
with nucleophilic groups in proteins and DNA, leading to
protein-protein and protein-DNA crosslinking. In these bac-
teria, FA is either assimilated by the serine or ribose mono-
phosphate pathway (RuMP) to be used as a major source of
cellular carbon or oxidized to generate NADH and formate by
LMW thiol-dependent formaldehyde dehydrogenases (Fdh).
Recently, a metabolomics approach identified a role for
BSH in FA detoxification in Bacillus methanolicus (90)
(Fig. 3D). B. methanolicus is a thermotolerant, facultative
methylotroph, making it a useful strain for the large-scale
production of amino acids frommethanol.When grown in the
presence of methanol, an S-formyl-BSH intermediate was
detected in cell lysates by LC-MS. The hydrolysis of related
S-formyl-GSH is usually catalyzed by S-formyl-GSH-
hydrolases that are homologs of human esterases and par-
ticipate in FA oxidation in GSH-producing bacteria (46). The
putative esterase that is specific for hydrolysis of S-formyl-
BSH is unknown in B. subtilis. The BSH-dependent FA ox-
idation pathway appears to be the most important under
conditions where the RuMP and THF pathways are over-
whelmed, such as on a rapid shift in carbon source from
mannitol to methanol. Non-methanotrophs, such as B. sub-
tilis, also use the RuMP pathway to detoxify FA. In addition,
transcriptomic and proteomic characterization of the B.
subtilis response to FA stress led to the identification of AdhA
as a putative LMW thiol-dependent Fdh that is induced under
FA and MG stress, although its precise role has not been
confirmed (Fig. 3D) (98).
BSH and Metal Homeostasis
Metal ions are essential for life, yet many fundamental
questions regarding the size of the cellular metal quota, how it
varies with growth conditions, and how it is modulated in
response to stress still remain. Metal deficiency leads to a
genome-wide response that serves to increase metal import,
decrease metal demand, mobilize stored metals, redistribute
metals from lower-priority enzymes to support higher-priority
needs, and replace metal-dependent enzymes with pathways
that are dependent on other cofactors (82). Conversely, metal
excess induces the expression of metal efflux systems to
prevent the mismetallation of essential enzymes and the
production of ROS (100). Both metal deficiency and excess
are utilized by the host immune system in response to path-
ogens (23, 103).
The chemical speciation of metals within cells is largely
unexplored. Metallation of metalloenzymes, and detection of
cellular metal status by metalloregulatory proteins, is gov-
erned by the labile metal pool, which is defined as those metal
ions that are hydrated or otherwise in a rapidly exchanging
form. LWM thiols in eukaryotic and GSH-producing bacteria
are known to participate in buffering the labile pool and in
detoxifying metal ions. GSH was shown to function together
with glutaredoxins in iron-sulfur (FeS)-cluster trafficking
since an FeS cluster could be assembled and bridged between
the active site Cys of monothiol Grx3/4 and GSH, as dem-
onstrated both in vitro and in vivo in yeast cells (67, 89, 108).
In plants and fungi, GSH is necessary for heavy-metal
sequestration as it is the major substrate for the synthesis of
the heavy metal-binding peptide phytochelatin (44). In yeast,
resistance to cadmium requires GSH (69). In contrast, the
contribution of LWM thiols to metal ion homeostasis is
poorly understood in non-GSH-producing bacteria (45, 48,
49). In the next section, we discuss the emerging role of BSH
as a key player in metal homeostasis.
Zinc buffering
Between 5% and 10% of proteins require Zn2+ as either a
structural or catalytic cofactor (3). Unlike Fe2+, which gener-
ates cell-damaging hydroxyl radicals in the presence of hy-
drogen peroxide (H2O2), Zn
2+ is not redox reactive, allowing it
to be adopted as a structural cofactor in a number of proteins.
Zn2+must be kept at a high enough concentration to ensure that
the Zn2+ quota is sufficient for Zn2+ to perform its essential
roles. However, since Zn2+, in general, binds with higher
avidity thanmost othermetals (except for Cu2+), Zn2+must not
be present in excess so that proteins utilizing other metals are
not mismetallated (58). Thus, the free steady-state Zn2+ levels
are highly regulated at multiple levels such that they are
buffered in with a total intracellular concentration of*1mM
and a free Zn2+ concentration in the*pM range (101).
The narrow range of intracellular free Zn2+ is set by Zn2+
sensing transcription factors (101). In B. subtilis, Zur acts as a
sensor of Zn2+ limitation and CzrA is a sensor of Zn2+ excess
(39, 88). These metalloregulators sense the labile Zn(II) pool,
consisting of Zn(II) bound reversibly to small molecules,
nucleotides, and proteins in a rapidly exchanging form. Un-
der conditions of Zn2+ sufficiency, the Zn2+-sensing tran-
scription factor Zur represses transcription of the Zn2+ uptake
systems. When Zn2+ is in excess, CzrA is inactivated, leading
to derepression of transcription of the cadA and czcD efflux
pumps and Zn2+ efflux. Organisms have also evolved Zn2+-
independent paralogs that can functionally replace Zn2+ re-
quiring proteins under Zn2+ starvation conditions (1, 91). In
addition, Zn2+ may be mobilized from a labile Zn2+ pool in
response to stress under non-steady state conditions. Work
from the Maret lab demonstrated that metallothionein (MT),
a cysteine-rich, Zn2+-binding LMW protein, serves as a zinc
‘‘sink’’ in eukaryotes and is able to control the availability of
kinetically available Zn2+ in response to oxidative stress (80).
Since B. subtilis utilizes BSH as the major LMW thiol and
does not produce MT or GSH, BSH could serve a similar
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function in metal buffering. BSH has several potential metal
coordinating ligands, including a sulfur-containing thiolate, a
primary amine, and two carboxylates (97). Genetic, physio-
logical and biochemical evidence suggests that, in B. subtilis
and related low G +C Firmicutes, BSH serves as the major
buffer of the labile Zn2+ pool (Fig. 5) (75). BSH binds Zn2+ as
a (BSH)2:Zn
2+ complex with an affinity (Ka) of 1.9 · 1012
M-2 (75). Given that the intracellular concentration of BSH
can range from 1 to 5mM (120), depending on the growth
phase, it is reasonable to suggest that BSH can account for
*1/3 of the total Zn2+ pool under Zn2+ excess conditions (75).
BSH may also have direct effects on Zn2+ sensing by Zur
and CzrA. In vitro experiments monitoring the binding
of CzrA to its operator site as a proxy for CzrA metallation
status demonstrated that Zn2+ dissociation from holo-CzrA
was much faster in the presence of BSH. This suggests that
BSH can facilitate Zn2+ loading and removal into CzrA,
presumably through a ligand-exchange mechanism that was
analogous to that described for Cu+ chaperones (116). This
may provide a mechanism for rapid re-repression of Zn2+
efflux if cells experience a sudden shift from Zn2+ excess to
starvation. Thus, BSH influences Zn2+ homeostasis at mul-
tiple levels as a significant intracellular Zn2+ buffer under
conditions of Zn2+ excess to prevent intoxication, and as a
facilitator of transcription regulation in response to fluctua-
tions in Zn2+ levels.
Iron-sulfur cluster assembly
The major cytosolic requirements for Fe2+ are for utiliza-
tion in heme-containing enzymes and the assembly of FeS
clusters. FeS cluster-containing proteins are involved in a
wide range of cellular functions (83). Many key enzymes in
amino acid biosynthesis, carbon metabolism, cofactor bio-
synthesis, and antibiotic resistance are dependent on FeS
cluster-containing enzymes. Thus, inactivation of these en-
zymes under conditions of Fe2+ starvation or oxidative stress
is detrimental for proliferation (57).
A broad phenotypic survey of a S. aureus strain lacking
BSH revealed many phenotypes that are consistent with de-
fects in FeS biogenesis (Fig. 5) (30, 118). S. aureus strains
lacking BSH are severely impaired for growth in media
lacking leucine (Leu) or isoleucine (Ile). This growth defect
could be suppressed by supplementation with either amino
acid or Fe2+. The activity of key FeS requiring dehydratase
enzymes in Leu or Ile biosynthesis is decreased in a BSH null
mutant strain. In addition, aconitase activity, an unrelated
FeS-dependent enzyme that catalyzes the conversion of cit-
rate to isocitrate, also decreased, suggestive of an overall
defect in cellular FeS cluster biogenesis.
The FeS biosynthetic machinery in S. aureus is encoded by
the suf operon, which utilizes cysteine as a sulfur source and
an unidentified Fe2+ source. On assembly, the FeS clusters are
transferred to FeS carrier proteins (Nfu and/or SufA) for
delivery to FeS-containing proteins (81). Genetic analysis
suggests that the role of BSH in FeS biogenesis is indepen-
dent of Nfu and SufA (118). Thus BSH, Nfu and SufA per-
form independent, yet overlapping roles in FeS biogenesis.
In yeast, monothiol glutaredoxins together with GSH play
a key role in FeS cluster biogenesis and trafficking (17, 67,
68, 89, 108). Grx3/4 were shown to bind a bridging [2Fe-2S]
cluster in vitro that is coordinated by the active-site Cys
residue of the Grx domain and GSH as ligands (67, 108). The
deficiency of Grx affected the synthesis of Fe/S clusters,
heme, and di-iron centers and thus, this Grx FeS center has a
crucial role in iron trafficking and sensing in yeast cells. It
remains an interesting question for future studies to unravel
whether BSH chelates Fe2+ directly or is involved in FeS
cluster assembly via a BSH-containing Brx FeS center that
perhaps could function in iron trafficking and sensing.
FIG. 5. The functions of BSH in metal homeostasis. A role for BSH in metal homeostasis has been identified for iron,
zinc, and copper. BSH is required for the full activity of FeS requiring proteins in S. aureus, possibly as a key component in
the assembly and delivery of FeS clusters. BSH is believed to function in an independent, yet overlapping role with the FeS
carrier proteins, SufA and Nfu. BSH can also bind zinc with a high affinity and serves as a major cytosolic zinc buffer as
demonstrated in B. subtilis, allowing the cell to avoid zinc intoxication under conditions of excess. Biochemical evidence
also suggests a role for BSH in facilitating the delivery and removal of zinc from the zinc-sensing metalloregulators, Zur
and CzrA. Lastly, BSH may also work in concert with CopZ in interacellular copper buffering and delivery to metallo-
proteins and may protect CopZ from overoxidation through S-bacilliothiolation. FeS, iron-sulfur.
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BSH may also have a role in maintaining the labile Fe2+
pool. In bacteria, Fe2+ sufficiency is sensed by the Fe2+-specific
metalloregulator, Fur (63). On Fe2+ sufficiency, B. subtilis Fur
binds Fe2+ at two different sensing sites, leading to DNA
binding and repression of its regulon (76). Fur controls a large
and complex regulon, including many iron uptake systems and
an iron efflux pump (PfeT) (4). In addition, Fur indirectly
regulates many more genes by repression of a small noncoding
RNA (FsrA) and putative RNA chaperones (FbpABC) that are
analogous in function to Hfq from enterobacteria, which to-
gether mediate an Fe2+-sparing response (36, 123, 124). A S.
aureus BSH null strain contains lower levels of Fur-accessible
Fe2+, as judged by slower transcriptional repression on Fe2+
sufficiency of the Fur-regulated isdB promoter, which is in-
volved in Fe2+ acquisition from heme (118).
Copper trafficking
Copper plays a critical role in many cellular processes, yet
Cu+ is highly toxic in excess due to enzyme mismetallation
(78, 79). Thus, bacteria have evolved mechanisms to limit
intracellular Cu+ toxicity by keeping it tightly bound to
proteins, thereby limiting deleterious side reactions. Delivery
of Cu+ into Cu+-containing proteins is often mediated by Cu+
chaperones, such as Atx1 in yeast (70) or possibly CopZ in B.
subtilis (5). CopZ is a Atx1-like protein that may sequester
excess intracellular Cu+ and deliver Cu+ to the CopA CPx-
type ATP-ase for efflux. Recent in vitro studies identified S-
bacillithiolated forms of apo-CopZ as well as CopZ loaded
with BSH:Cu+ adducts (Fig. 5) (60). Further biochemical
analysis revealed that BSH binds Cu+ with a relatively high
affinity of b2(BSH) = 4 · 1017 M-2 and a stoichiometry of 2
BSH to 1 Cu+, indicating a possible role for BSH in intracellular
Cu+ buffering. Cells lacking BSH are no more sensitive to Cu+
than wild-type cells. Interestingly, expression of the CsoR-
regulated, Cu+-responsive copZA operon is induced in the ab-
sence of BSH, suggesting elevated levels of labile Cu+ and a role
for BSH in Cu+ buffering (75). However, the precise in vivo role
of BSH in Cu+ homeostasis remains to be determined.
Functions of BSH in S. aureus Virulence
BSH also plays an important role under infection-like
conditions in the S. aureus clinical isolates, as shown in two
phenotype studies using macrophage infection assays (111,
112). BSH-deficient mutants in clinical MRSA strains COL
and USA300 showed a decreased survival in human whole-
blood survival assays (111). In microarray analyses, the bio-
synthetic operon for staphyloxanthin was upregulated and the
staphyloxanthin level was strongly decreased in the bshA
mutant, suggesting lower radical scavenging ability in the
absence of BSH. Staphyloxanthin is a carotenoid pigment that
is produced by some S. aureus strains and is responsible for
the yellow color from which the species name is derived.
Staphyloxanthin provides protection against oxidative stress
in neutrophil-infection assays and enhances the fitness of S.
aureus (16).
Among the various S. aureus clonal complexes, it was
found that natural BSH-deficient S. aureus strains have
evolved that belong to the S. aureusNCTC8325 lineage (e.g.,
strain SH1000). They carry a bshC null mutation due to an
8 bp duplication in the bshC gene as a possible remnant of a
transposon insertion (95, 111, 112). The natural S. aureus
SH1000 bshC mutant was compromised in survival during in-
fection assays using murine macrophages and human epithelial
cell lines in comparison to the repaired and bshC-complemented
S. aureus SH1000 strain (111, 112). Thus, BSH is an important
virulence factor contributing to pathogen fitness and provides
protection against the host-immune system in S. aureus clinical
MRSA isolates under infection-related conditions.
This makes the BSH biosynthesis enzymes attractive drug
targets for the treatment of emerging MRSA infections. In
particular, BshB inhibitors would be good candidates for
anti-infectives that block biosynthesis and salvage of BSH.
Future studies should be directed toward unraveling the
mechanisms of virulence control by BSH in S. aureus, which
could involve S-bacillithiolation of key enzymes or regulators.
Protein S-Bacillithiolation and Its Reversal by Brx
Targets of protein S-bacillithiolation in B. subtilis
and S. aureus
In eukaryotes, protein S-glutathionylation functions as an
important thiol-protection and redox-regulatory mechanism
and is implicated in many physiological and pathophys-
iological processes, such as neurodegenerative and car-
diovascular diseases, cancer, and diabetes (18, 42, 43). In
Firmicutes, BSH plays a related role in a redox modification
termed protein S-bacillithiolation (Fig. 6) (74). Protein S-
bacillithiolation was first discovered as redox modification of
the organic hydroperoxide repressor OhrR under cumene
hydroperoxide (CHP) stress (Fig. 7). OhrR is inactivated due
to S-bacillithiolation at its lone Cys15 residue under CHP
stress, leading to upregulation of the OhrA peroxiredoxin that
is involved in CHP detoxification (35, 64). However, OhrR is
also involved in redox sensing of hypochloric acid and is
inactivated by S-bacillithiolation under NaOCl stress, leading
to ohrA derepression that confers resistance against NaOCl
stress in B. subtilis (14). Thus, S-bacillithiolation functions as
a redox-switch mechanism to control the activity of the
redox-sensing transcription factor OhrR in B. subtilis in re-
sponse to both CHP and NaOCl treatment.
Although the role of the OhrA peroxiredoxin in the de-
toxification of organic hydroperoxides to their corresponding
alcohols is well known in several bacteria (24), the function
of OhrA in NaOCl detoxification has still to be demonstrated
in vitro. Moreover, there are two OhrR homologs encoded in
the genomes of S. aureus, SarZ and MgrA, controlling ohrA
homologs and large regulons for antibiotics resistance de-
terminants and virulence factors (12). Evidence for the redox
control and structural changes of SarZ and MgrA at the
conserved single Cys by S-thiolation was demonstrated by
using a synthetic thiol, benzene thiol in vitro (110). Recently,
the quantitative redox proteomics approach OxICAT re-
vealed increased oxidation of both SarZ and MgrA under
NaOCl stress in S. aureus USA300, suggesting their redox
regulation by S-bacillithiolation in vivo (56).
Apart fromOhrR, the methionine synthaseMetE was iden-
tified as the most abundant S-bacillithiolated protein in
Bacillus species under NaOCl stress (Fig. 7). S-bacillithiolation
of MetE was observed when cells were grown in minimal me-
dium under NaOCl stress and MetE-SSB could be visualized
as a major band in BSH-specific Western blots under NaOCl
and diamide stress. MetE was S-bacillithiolated at its Zn-
binding active site Cys730 and at the non-essential surface-
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exposed Cys719, causing a methionine auxotrophy phenotype
under NaOCl stress (12). MetE is also a main target for
S-glutathionylation and the most susceptible protein for thiol-
oxidation in E. coli under diamide treatment (52, 66). S-
glutathionylation of MetE occurs at a non-conserved Cys645
that is located at the entrance to the active site, also leading
to methionine auxotrophy in E. coli (52).
We have shown that the conserved Zn-binding active site
forms the mixed disulfide with BSH in B. subtilis, which is
also target for S-mycothiolation in C. glutamicum under
NaOCl stress (13). Inactivation of MetE under NaOCl stress
in B. subtilis is accompanied by an increased transcription of
the S-box regulon controlling genes for methionine biosyn-
thesis. It is hypothesized that MetE inactivation could lead to a
translation arrest to enable detoxification of hypochlorite and
to avoid further protein damage. Further support for this pos-
tulated translation stop is provided by the observation that
other amino acid biosynthesis enzymes (AroA), protein
translation factors (Tuf), and ribosomal proteins (RpsM) are
also targets for S-thiolation across Gram-positive bacteria (14).
In S. aureus, S-bacillithiolation was recently shown to
control the activity of the glycolytic enzyme glyceraldehyde-
3-phosphate dehydrogenase (Gap) of S. aureus under NaOCl
stress (Fig. 7) (56). Gap is S-bacillithiolated at the conserved
active site Cys151, which is a well-known target for vari-
ous post-translational thiol-modifications, also including S-
glutathionylation in eukaryotes. The reactivity of the Gap
active site was shown to depend on a specific H2O2-binding
pocket, transition state stabilization, and a proton relay
mechanism promoting leaving-group departure (51, 105).
In S. aureus, Gap contributes as the most abundant Cys
protein in the proteome, with 4% to the total Cys proteome of
S. aureus and the S-bacillithiolated Gap was observed as a
major band in NaOCl-treated cells using BSH-specific
Western blots (56). Using OxICAT, Gap showed the
highest oxidation increase of 29% at the S-bacillithiolated
active site Cys151 under NaOCl stress. Detailed Gap activity
assays in the presence of H2O2 and NaOCl with or without
BSH revealed that Gap inactivation is faster due to S-
bacillithiolation compared with overoxidation. These results
lead to the conclusion that S-bacillithiolation of the Gap ac-
tive site can efficiently prevent its irreversible overoxidation
under both H2O2 and NaOCl treatments. Molecular docking
of BSH into the Gap active site was used tomodel the structure
of the S-bacillithiolated active site. The model of the Gap-SSB
structure suggests that BSH can undergo disulfide formation
with Cys151without major conformational changes. This may
explain why the most abundant Cys-protein Gap is the pre-
ferred and dominant target for S-bacillithiolation inside S.
aureus cells (56).
Protein S-bacillithiolation is a widespread thiol-protection
and redox-regulatorymechanism in different Firmicutes under
hypochlorite stress, including industrially important Bacillus
and Staphylococcus species, such as B. subtilis, Bacillus
amyloliquefaciens, Bacillus megaterium, Bacillus pumilus,
and the meat-starter culture Staphylococcus carnosus (8, 14,
74). Eight common and 29 unique S-bacillithiolated proteins
were identified in the different Firmicutes using shotgun pro-
teomics based on the mass increase of 396 Da at Cys residues
(14, 15). The complete set of S-bacillithiolated proteins (the
S-bacillithiolome) includes antioxidant function proteins, such
as peroxiredoxins (YkuU), thiol-disulfide oxidoreductases
(YumC) and Brx (YphP YqiW, YtxJ), translation factors
(Tuf), chaperones (DnaK, GrpE), and several metabolic en-
zymes involved in the biosynthesis of amino acids, cofactors,
and nucleotides. The translation elongation factor TufA,
the methionine synthase MetE and its homolog YxjG, the in-
osine monophosphate dehydrogenase GuaB, and the inorganic
pyrophosphatase PpaC belong to the conserved targets for S-
bacillithiolation across Firmicutes bacteria that are also mod-
ified by S-mycothiolation in Actinomycetes (13).
Surprisingly, the glycolytic Gap is the major target for
S-bacillithiolation in S. aureus (56), but Gap is not S-
bacillithiolated in Bacillus species. Instead, the Gap enzyme
of B. subtilis is oxidized to an intramolecular disulfide in its
highly conserved CTTNC motif under NaOCl stress, as
confirmed by mass spectrometry (14). This intracellular
disulfide was also shown for the E. coli Gap homolog under
NaOCl stress, since both Cys residues showed increased
oxidations in the OxICAT analysis (65). However, in S. au-
reus Gap, the second Cys in this CTTNC motif is replaced by
a serine explaining the preference of Cys151 for S-
-bacillithiolation under NaOCl stress.
All global S-bacillithiolome studies to date identified S-
bacillithiolated proteins in Firmicutes bacteria by mass spec-
trometry and non-reducing BSH-Western blot analyses under
NaOCl and diamide stress, but not under H2O2 stress in vivo
(15). Previously, strongly increased S-thiolations were also
observed at the global level under diamide stress in B. subtilis
and S. aureus (113). S-glutathionylation requires activation of
thiols to sulfenic acid, sulfenylamides, thiyl radicals, thio-
sulfinate, or S-nitrosyl intermediates that, subsequently, react
FIG. 6. Mechanisms of S-bacillithiolation and its re-
versal. Proteins are S-bacillithiolated under CHP, HOCl,
and diamide stress in Bacillus and Staphylococcus species.
Diamide is a reactive electrophile species leading directly to
the formation of mixed BSH disulfides. CHP and HOCl
activate thiols to a sulfenic acid (-SOH) and sulfenylchloride
(-SCl) intermediates, respectively, that react further with
BSH to form S-bacillithiolated proteins. In the absence of
proximal thiols, -SOH and -SCl are overoxidized to sulfinic
or sulfonic acids. Thus, S-bacillithiolation serves to protect
vulnerable thiols against irreversible overoxidation. The
asterisk indicates that often active site Cys residues are tar-
gets for S-bacillithiolation. The reversal of S-bacillithiolation
is catalyzed by the BrxA/B. Brx, bacilliredoxin; CHP, cu-
mene hydroperoxide.
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further with GSH to the mixed disulfide (2, 41, 85, 86). Hy-
pochlorite activates the thiol group via chlorination, leading
to an unstable sulfenylchloride intermediate that quickly re-
acts further to generate S-bacillithiolations (Fig. 6) (19, 47).
Diamide is a reactive electrophile known to form mixed
disulfides, including S-thiolations in several organisms (113).
The second-order rate constant of the reaction of HOCl with
thiols is seven orders of magnitude higher compared with
H2O2 (19, 104), explaining why S-bacillithiolation was not
observed under H2O2 stress in vivo. Moreover, the pathogen
S. aureus exhibits a remarkable resistance to 200mM H2O2
due to efficient detoxification mechanisms that allow the
survival under infection conditions (55, 73).
Apart from H2O2, S. aureus encounters HOCl during in-
fections by activated neutrophils that is produced by mye-
loperoxidase (134), and hence, S-bacillithiolation serves as a
major thiol-protection mechanism of essential enzymes, such
as Gap under infection-related HOCl stress conditions. It will
be interesting to uncover the targets for S-bacillithiolation
during infections, or in the anterior nares as the natural niche
of S. aureus in future studies.
The BrxA and BrxB function
in protein de-bacillithiolation
The Trx-fold proteins YtxJ, BrxA (YphP), and BrxB
(YqiW) were identified as S-bacillithiolated in B. subtilis and
S. carnosus that co-occur with the BSH biosynthesis enzymes
(BshA, BshB, BshC) only in BSH-producing Firmicutes
bacteria and were suggested to function as Brx in the reversal
of S-bacillithiolations (Fig. 8A, B) (15). YtxJ is suggested as
a monothiol Brx with the active site Cys located in a con-
served TCPIS motif.
BrxA (YphP) and BrxB (YqiW) are DUF1094-family
proteins with unusual CGC active site motifs, rather than the
more common CxxC spacing seen in glutaredoxin (38, 40).
BrxA was originally suggested to function as a thiol-disulfide
isomerase based on its high standard redox potential of
FIG. 7. Physiological roles of S-bacillithiolations for OhrR and MetE in B. subtilis and for Gap of S. aureus. NaOCl
leads to S-bacillithiolation of OhrR and MetE as main targets in B. subtilis that have regulatory roles under NaOCl stress. S-
bacillithiolation inactivates the OhrR repressor, leading to induction of the OhrA peroxiredoxin that confers resistance to
NaOCl and OHP. S-bacillithiolation of the methionine synthase MetE at its active site Cys730 and of other enzymes of the
Cys and Met biosynthesis pathway (YxjG, PpaC, SerA, MetI) leads to methionine auxotrophy. In S. aureus, the glycolytic
Gap is the main target for S-bacillithiolation under NaOCl stress. S-bacillithiolation of the Gap active site Cys151 leads to
reversible Gap inactivation and prevents its overoxidation to Cys sulfonic acid. Gap inactivation under oxidative stress
might redirect the glycolytic flux into the PPP for NADPH regeneration, as shown in yeast cells. Gap, glyceraldehyde-3-
phosphate dehydrogenase; OHP, organic hydroperoxide; PPP, pentose phosphate pathway.
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E0¢ = -130mV (22). However, both BrxA and BrxB function
in the reduction of the S-bacillithiolated MetE and OhrR
in vitro, therebydemonstratingBrx activity (38). TheBrxBCGA-
resolving Cys mutant could regenerate DNA-binding activity of
S-bacillithiolated OhrR in vitro, but S-cysteinylated OhrR could
not be reactivated. MetE de-bacillithiolation was catalyzed
by the BrxBCGA mutant as revealed by non-reducing BSH-
specific Western blot analysis and mass spectrometry, but
MetE reactivation could not be demonstrated in vitro. In S.
aureus, Gap is the major S-bacillithiolated protein under
NaOCl stress and Gap activity could be fully restored by using
the BrxA (YphP) homolog SAUSA300_1321 (Brx) and the
BrxCGA-resolving Cys mutant in vitro (56).
In conclusion, the BrxA and BrxB have been characterized
to catalyze the de-bacillithiolation of two essential metabolic
enzymes (MetE and Gap) and of the redox-sensing regulator
OhrR in B. subtilis or S. aureus. These results provide evi-
dence for the function of glutaredoxin-like Brx in industrially
and medically important BSH-producing bacteria. However,
phenotypic analyses of brxA and brxB single and double
mutants revealed no significant growth phenotypes under
NaOCl stress in B. subtilis (38). Thus, the Brx pathway is not
essential and the Trx pathwaymight be alternatively involved
in the de-bacillithiolation in B. subtilis.
A Brx-roGFP2 biosensor monitors dynamic changes
in the BSH redox potential in S. aureus
Recently, Brx (YphP) was fused to redox-sensitive GFP
(roGFP2) to construct a genetically encoded Brx-roGFP2
biosensor to monitor dynamic changes in the BSH redox
potential in S. aureus (Fig. 8C, D) (73). Brx-roGFP2 responds
specifically only to physiological concentrations of BSSB
in vitro, but it does not react with other thiol disulfides
(cystine, GSSG, MSSM, CoASH disulfides). This further
confirms the specificity of Brx for the reduction of BSH
mixed disulfides in S. aureus.
The specificity of the Brx-roGFP2 biosensor to low doses
of BSSB was shown to depend on the Brx active site in vitro,
whereas direct responses of the roGFP2 to the oxidants
in vivo could not be excluded. Brx-roGFP2 was shown to
react very fast in S. aureus COL to low doses of 20–100lM
NaOCl in vivo, but high doses of a maximum of 100mM
H2O2 did not lead to complete biosensor oxidation. This
confirms the high reactivity of NaOCl inside S. aureus that
requires fast thiol protection by S-bacillithiolation to avoid
the overoxidation of thiols. The weak biosensor response to
H2O2 can be explained by the high level of peroxide resis-
tance in S. aureus.
This Brx-roGFP2 biosensor was further applied to investi-
gate the involvement of oxidative stress in the killing mode of
antibiotics in S. aureus (73). The role of ROS in the mecha-
nism of action of bactericidal antibiotics has been a subject of
controversy (61, 71). Antibiotics that are commonly used to
treat S. aureus infections were selected that target the RNA
polymerase (rifampicin), cell-wall biosynthesis (fosfomycin,
ampicillin, oxacillin, and vancomycin), protein biosynthesis
(gentamycin, lincomycin, erythromycin, and linezolid), and
DNA replication (ciprofloxacin). These different antibiotics
classes did not lead to changes in the BSH redox potential at
FIG. 8. Structure of the BrxA (YphP) of B. subtilis (A), Brx redox pathway (B), principle of Brx-roGFP2 biosensor
oxidation (C), and ratiometric change of excitation spectra of Brx-roGFP2 by BSSB in vitro (D). (A) The structure of
the BrxA (YphP) with the CGC active site motif was generated by using the software Phyre2 and PyMol. (B) BrxA reduces
S-bacillithiolated proteins, resulting in Brx-SSB formation. Recycling of BrxA may require BSH and an NADPH-dependent
BSSB reductase that could be YpdA. (C) The Brx-roGFP2 biosensor reacts first with BSSB at the active site Cys of Brx,
leading to Brx-SSB formation, subsequent transfer of the BSH moiety to the coupled roGFP2, and re-arrangement to the
roGFP2 disulfide. The roGFP2 disulfide causes a change of the 405/488 nm excitation ratio. (D) Brx-roGFP2 reacts very fast
with purified 100 lM BSSB, as shown by the ratiometric change in the excitation maxima at 405 and 488 nm. For fully
oxidized and reduced probes, Brx-roGFP2 was treated with 5mM diamide and 10mM DTT, respectively. The Brx-roGFP2
fluorescence excitation spectra were monitored by using the Clariostar microplate reader. Adapted from a previous pub-
lication (73). BSSB, oxidized bacillithiol disulfide.
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sub-lethal concentrations, indicating that these antibiotics do
not impose strong oxidative stress in S. aureus.
These results are consistent with roGFP2 biosensor results
obtained in Salmonella under antibiotic treatment (131).
However, due to its high peroxide resistance, S. aureus might
be able to quickly detoxify ROS generated during antibiotic
treatment. In the case of fosfomycin, BSH is directly required
as a cofactor for FosB for detoxification in S. aureus (111).
However, previous studies found no correlation between the
level of fosfomycin resistance and BSH levels in different S.
aureus clinical isolates, and no increased BSH redox potential
was measured under fosfomycin treatment in S. aureus COL.
The Brx-roGFP2 biosensor was further expressed in two
MRSA isolates, S. aureus COL and USA300, and the latter is
highly virulent community-acquired MRSA. An increased
BSH redox potential was measured during the entry into sta-
tionary phase in both strains, ranging from-300 to -270mV in
COL and from -300 to -235mV in USA300 along the growth
curve. Our future studies are directed to apply this Brx-roGFP2
biosensor for screening of the BSH redox potential across S.
aureus isolates of different clonal complexes to reveal the
differences in pathogen fitness and in their ROS detoxification
capacities as defense mechanisms against the host immune
system.
Concluding Remarks
In a previous review in this journal (50),written soon after the
discovery of BSH, readers were introduced to this novel thiol
and given a preview of how the field might develop, guided by
analogy with the prior extensive work on GSH and, to a lesser
extent, MSH. Many of the predictions made at that time have
held true, but there have also been many surprises as well as
frustrations. Here, we briefly highlight some of the pressing
questions in the field that have not yet been resolved, although
ongoing efforts will surely work to address these challenges.
Although the biosynthetic pathway of BSH is now well
established, and extensive structural and biochemical studies
have led to a detailed understanding of this process, the actual
reaction catalyzed by BshC is still undetermined. The analo-
gous enzyme for MSH synthesis uses aminoacylated tRNACys
as an activated form of Cys. We assume that BshC also re-
quires an activated form of Cys, but the identity of this last
substrate is unknown. Another key ‘‘missing’’ activity for our
understanding of BSH biology is the BSSB reductase. Cer-
tainly, the B. subtilis YpdA protein (a TrxR homolog) is an
attractive candidate, but attempts to demonstrate BSSB ac-
tivity biochemically have been unsuccessful.
Although many of the proteins involved in the core me-
tabolism of BSH are, by now, known, including the biosyn-
thesis pathway and Brx, many BSH-utilizing enzymes and
accessory functions are yet to be discovered. There are sev-
eral peroxidases annotated as Gpx, thiol-peroxidase, or thiol-
dependent peroxiredoxin in Bacillus and Staphylococcus
species that could use BSH as a thiol cofactor for peroxide
detoxification (Fig. 3E). It is also unclear as to whether BSH
(or perhaps BSSB) is imported or exported from cells. In E.
coli, GSH is exported to the periplasm (109), but an analogous
process for BSH is not established. It is worth noting that B.
subtilis has multiple importers assigned as having a role in
cystine uptake (9), but it is not known as to whether one or
more may, in addition, or instead, use BSSB as a substrate.
Although the role of BSH in thiol redox chemistry is well
established, there are also other aspects that are still largely
unexplored. As noted earlier, in some cases, BSH may play a
key role in protecting cells against H2S stress (122), and by
analogy with GSH a role in protection against reactive ni-
trogen species can be predicted. Although BSH has already
been investigated for its role in buffering of Zn2+ (25, 75) and
in the assembly of FeS clusters (30, 117, 118), many details
remain to be discovered, such as the possible roles of BSH and
other thiols together with Brx (glutaredoxin-like enzymes) in
bridging FeS clusters, analogous to the role of GSH and Grx
proteins in iron trafficking and sensing in GSH-producing
eukaryotic organisms.
Similarly, proteomics studies have documented an
abundance of protein S-bacillithiolation as a major post-
translational modification under oxidative stress conditions
(14, 15, 56, 64, 74, 107), but the pathways that reverse this
modification (Brx) and the consequences for enzyme activity
are still only now emerging. On a broader level, a clear pic-
ture has not yet emerged as to which bacteria synthesize BSH
instead of GSH (or MSH), and whether one offers specific
advantages over the other. We look forward to the continued
rapid progress in this area and the resolution of these ques-
tions, and others not yet even imagined.
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BshA¼ glycosyltransferase for GlcNAc-Mal
biosynthesis
BshB¼ deacetylase-producing GlcN-Mal
BshC¼ cysteine ligase for BSH biosynthesis











Gap¼ glycolytic glyceraldehyde -3-phosphate
dehydrogenase
GlcNAc¼N-acetyl glucoseamine
GlxA/B¼ glyoxalases A and B
Grx¼ glutaredoxin
GSH¼ glutathione





LC-MS/MS¼ liquid chromatography tandem mass
spectrometry










NADH¼ nicotinamide adenine dinucleotide




OhrR¼ organic hydroperoxide repressor
PPP¼ pentose phosphate pathway
protein-SSB¼BSH protein mixed disulfide
roGFP2¼ redox-sensitive green fluorescent protein
ROH¼ organic alcohol
ROS¼ reactive oxygen species
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